StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Galleri

<< Previous

Bullboard Posts

Next >>

Comment by OakTreeforest39on Jun 08, 2021 8:15am

177 Views

Post# 33346362

RE:RE:RE:RE:RE:RE:Galleri

That's why I'm so patient with szls....you have 8 billions on one side and the 35 millions SZLS on the other side with a working Aristotle and cash cow covid....and all the prospects in inflammatory diseases and others....! One day or another I cannot believe that we are not going to get a market cap in the middle! If not, szls it's the best exemple on how irrational the stock market is!

glta

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks